Is thalidomide effective for the treatment of gastrointestinal bleeding in hereditary hemorrhagic telangiectasia?

Pérez Encinas, Manuel Mateo; Rabuñal Martínez, María; Bello López, José Luis
Thumbnail
Statistics
Statistics
Identifiers
Identifiers
URI: http://hdl.handle.net/20.500.11940/22583
PMID: 12161379
ISSN: 0390-6078
Full record
Services
Services
RISMendeleyLinksolver
Files view or download
Files view or download
Date issued
2002
Journal title
Haematologica
Type of content
Artigo
DeCS
telangiectasia hemorrágica hereditaria | talidomida | humanos | hemorragia gastrointestinal | electrocoagulación
MeSH
Gastrointestinal Hemorrhage | Thalidomide | Humans | Telangiectasia, Hereditary Hemorrhagic | Electrocoagulation
CIE
Telangiectasia hemorrágica hereditaria
Abstract
[EN] Clinical case. A patient diagnosed of hereditary hemorragic telangiectasia(HHT) who presented recurrents gastrointestinal bleeding and a multiple myeloma was treated with thalidomide. After two months of therapy the episodies of bleeding stopped. This case suggest that thalidomide is effective for the management of HHT patients.
Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)
Except where otherwise noted, this item's license is described as Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)